CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Teyi Pharmaceutical Group Co Ltd Company Snapshot
Teyi Pharmaceutical Group Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Teyi Pharmaceutical Group Co Ltd with three other companies in this sector in China: Zhejiang Starry Pharmaceutical Co Ltd (2018 sales of 890.47 million Chinese Renmimbi [US$126.51 million] of which 84% was Contrast Agent), Honz Pharmaceutical Co Ltd (882.66 million Chinese Renmimbi [US$125.40 million] of which 57% was Pharmaceutical Production and Sales Repo), and Shang Hai Kai Kai Industry Co Ltd (877.57 million Chinese Renmimbi [US$124.68 million] ).

Sales Analysis. Teyi Pharmaceutical Group Co Ltd reported sales of 884.98 million Chinese Renmimbi (US$125.73 million) for the year ending December of 2018. This represents an increase of 28.8% versus 2017, when the company's sales were 686.94 million Chinese Renmimbi. Sales at Teyi Pharmaceutical Group Co Ltd have increased during each of the previous five years (and since 2013, sales have increased a total of 158%). Sales of Pharmaceutical Industry saw an increase of 31.6% in 2018, from 641.35 million Chinese Renmimbi to 844.24 million Chinese Renmimbi. Not all segments of Teyi Pharmaceutical Group Co Ltd experienced an increase in sales in 2018: sales of Pharmaceutical Business fell 13.8% to 22.24 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Teyi Pharmaceutical Group Co Ltd
  Stock Performance Chart for Teyi Pharmaceutical Group Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (12/13/2019): 16.40
(Figures in Chinese Renmimbi)
1 Week 1.2%   13 Weeks 1.5%  
4 Weeks 2.6%   52 Weeks 24.7%  
 
Teyi Pharmaceutical Group Co Ltd Key Data:
  Ticker: 002728 Country: China
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 884,975,625
(Year Ending Jan 2019).
Employees: 1,280
  Currency: Chinese Renmimbi Market Cap: 3,469,618,504
  Fiscal Yr Ends: December Shares Outstanding: 200,904,372
  Share Type: A Gu Closely Held Shares: 139,299,585
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.